The Pharmacologic Basis of Neuroleptic Malignant Syndrome
- 1 March 1991
- journal article
- Published by SLACK, Inc. in Psychiatric Annals
- Vol. 21 (3) , 152-156
- https://doi.org/10.3928/0048-5713-19910301-07
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- NEUROLEPTIC MALIGNANT SYNDROME AFTER CLOZAPINE PLUS CARBAMAZEPINEThe Lancet, 1988
- Increased Extrapyramidal Symptoms with Addition of Lithium to NeurolepticsJournal of Nervous & Mental Disease, 1988
- Neuroleptic malignant syndrome: review and analysis of 115 casesBiological Psychiatry, 1987
- Apparent Neuroleptic Malignant Syndrome with Clozapine and LithiumJournal of Nervous & Mental Disease, 1986
- Lithium-Neuroleptic Neurotoxicity in the ElderlyJournal of Clinical Psychopharmacology, 1986
- The neuroleptic malignant syndrome: agent and host interactionActa Psychiatrica Scandinavica, 1986
- Neurotoxicity with combined administration of lithium and a neurolepticComprehensive Psychiatry, 1982
- Neuroleptic Malignant syndrome caused by dopamine‐depleting drugs in a patient with Huntington diseaseNeurology, 1981
- Adverse reactions in treatment with lithium carbonate and haloperidolJAMA, 1976
- Lithium carbonate, haloperidol, and irreversible brain damagePublished by American Medical Association (AMA) ,1974